Lessa, Fernanda C.
Milucky, Jennifer
Rouphael, Nadine G.
Bennett, Nancy M.
Talbot, H. Keipp
Harrison, Lee H.
Farley, Monica M.
Walston, Jeremy
Pimenta, Fabiana
Gertz, Robert E.
Rajam, Gowrisankar
Carvalho, Maria da Gloria
Beall, Bernard
Whitney, Cynthia G.
Funding for this research was provided by:
U.S. Department of Health & Human Services | Centers for Disease Control and Prevention (CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701, CDC-RFA-CK17-1701)
Article History
Received: 13 August 2018
Accepted: 8 November 2018
First Online: 19 December 2018
Competing Interests
: Dr. Lee Harrison has served on a scientific advisory board for GlaxoSmithKline, and has been a speaker at a Merck scientific symposium. However, none of these commitments had an influence on the design and interpretation of the data. All other authors report no competing financial or non-financial interests related to the work described.